Your browser doesn't support javascript.
loading
Development of miniature base editors using engineered IscB nickase.
Han, Dingyi; Xiao, Qingquan; Wang, Yifan; Zhang, Hainan; Dong, Xue; Li, Guoling; Kong, Xiangfeng; Wang, Shihao; Song, Jinhui; Zhang, Weihong; Zhou, Jingxing; Bi, Lanting; Yuan, Yuan; Shi, Linyu; Zhong, Na; Yang, Hui; Zhou, Yingsi.
Affiliation
  • Han D; Institute of Neuroscience, State Key Laboratory of Neuroscience, Key Laboratory of Primate Neurobiology, CAS Center for Excellence in Brain Science and Intelligence Technology, Shanghai Research Center for Brain Science and Brain-Inspired Intelligence, Shanghai Institutes for Biological Sciences, Ch
  • Xiao Q; College of Life Sciences, University of Chinese Academy of Sciences, Beijing, China.
  • Wang Y; Institute of Neuroscience, State Key Laboratory of Neuroscience, Key Laboratory of Primate Neurobiology, CAS Center for Excellence in Brain Science and Intelligence Technology, Shanghai Research Center for Brain Science and Brain-Inspired Intelligence, Shanghai Institutes for Biological Sciences, Ch
  • Zhang H; HUIDAGENE Therapeutics Inc., Shanghai, China.
  • Dong X; HUIEDIT Therapeutics Inc., Shanghai, China.
  • Li G; Institute of Neuroscience, State Key Laboratory of Neuroscience, Key Laboratory of Primate Neurobiology, CAS Center for Excellence in Brain Science and Intelligence Technology, Shanghai Research Center for Brain Science and Brain-Inspired Intelligence, Shanghai Institutes for Biological Sciences, Ch
  • Kong X; College of Life Sciences, University of Chinese Academy of Sciences, Beijing, China.
  • Wang S; HUIDAGENE Therapeutics Inc., Shanghai, China.
  • Song J; HUIEDIT Therapeutics Inc., Shanghai, China.
  • Zhang W; HUIDAGENE Therapeutics Inc., Shanghai, China.
  • Zhou J; HUIDAGENE Therapeutics Inc., Shanghai, China.
  • Bi L; HUIDAGENE Therapeutics Inc., Shanghai, China.
  • Yuan Y; HUIEDIT Therapeutics Inc., Shanghai, China.
  • Shi L; HUIDAGENE Therapeutics Inc., Shanghai, China.
  • Zhong N; HUIDAGENE Therapeutics Inc., Shanghai, China.
  • Yang H; HUIEDIT Therapeutics Inc., Shanghai, China.
  • Zhou Y; HUIDAGENE Therapeutics Inc., Shanghai, China.
Nat Methods ; 20(7): 1029-1036, 2023 07.
Article in En | MEDLINE | ID: mdl-37231266

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Deoxyribonuclease I / CRISPR-Cas Systems Limits: Animals / Humans Language: En Journal: Nat Methods Journal subject: TECNICAS E PROCEDIMENTOS DE LABORATORIO Year: 2023 Type: Article Affiliation country: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Deoxyribonuclease I / CRISPR-Cas Systems Limits: Animals / Humans Language: En Journal: Nat Methods Journal subject: TECNICAS E PROCEDIMENTOS DE LABORATORIO Year: 2023 Type: Article Affiliation country: Switzerland